BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20072159)

  • 1. Epigenetic plasticity of hTERT gene promoter determines retinoid capacity to repress telomerase in maturation-resistant acute promyelocytic leukemia cells.
    Azouz A; Wu YL; Hillion J; Tarkanyi I; Karniguian A; Aradi J; Lanotte M; Chen GQ; Chehna M; Ségal-Bendirdjian E
    Leukemia; 2010 Mar; 24(3):613-22. PubMed ID: 20072159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-expression of DNA methylation-silenced CD44 gene in a resistant NB4 cell line: rescue of CD44-dependent cell death by cAMP.
    Abecassis I; Maes J; Carrier JL; Hillion J; Goodhardt M; Medjber K; Wany L; Lanotte M; Karniguian A
    Leukemia; 2008 Mar; 22(3):511-20. PubMed ID: 18094716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex context relationships between DNA methylation and accessibility, histone marks, and hTERT gene expression in acute promyelocytic leukemia cells: perspectives for all-trans retinoic acid in cancer therapy.
    Garsuault D; Bouyer C; Nguyen E; Kandhari R; Prochazkova-Carlotti M; Chevret E; Forgez P; Ségal-Bendirdjian E
    Mol Oncol; 2020 Jun; 14(6):1310-1326. PubMed ID: 32239597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation.
    Pendino F; Sahraoui T; Lanotte M; Ségal-Bendirdjian E
    Leukemia; 2002 May; 16(5):826-32. PubMed ID: 11986943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation.
    Pendino F; Flexor M; Delhommeau F; Buet D; Lanotte M; Segal-Bendirdjian E
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6662-7. PubMed ID: 11371621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
    Atkinson SP; Hoare SF; Glasspool RM; Keith WN
    Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site.
    Zinn RL; Pruitt K; Eguchi S; Baylin SB; Herman JG
    Cancer Res; 2007 Jan; 67(1):194-201. PubMed ID: 17210699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid receptor alpha and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death.
    Pendino F; Dudognon C; Delhommeau F; Sahraoui T; Flexor M; Bennaceur-Griscelli A; Lanotte M; Ségal-Bendirdjian E
    Oncogene; 2003 Dec; 22(57):9142-50. PubMed ID: 14668795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene.
    Zhu Q; Liu C; Ge Z; Fang X; Zhang X; Strååt K; Björkholm M; Xu D
    PLoS One; 2008 Jan; 3(1):e1446. PubMed ID: 18197256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays.
    Nouzova M; Holtan N; Oshiro MM; Isett RB; Munoz-Rodriguez JL; List AF; Narro ML; Miller SJ; Merchant NC; Futscher BW
    J Pharmacol Exp Ther; 2004 Dec; 311(3):968-81. PubMed ID: 15302897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene.
    Devereux TR; Horikawa I; Anna CH; Annab LA; Afshari CA; Barrett JC
    Cancer Res; 1999 Dec; 59(24):6087-90. PubMed ID: 10626795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C/EBPα and PU.1 are involved in distinct differentiation responses of acute promyelocytic leukemia HL-60 and NB4 cells via chromatin remodeling.
    Savickiene J; Treigyte G; Vistartaite G; Tunaitis V; Magnusson KE; Navakauskiene R
    Differentiation; 2011 Jan; 81(1):57-67. PubMed ID: 20864248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase regulation by the long non-coding RNA H19 in human acute promyelocytic leukemia cells.
    El Hajj J; Nguyen E; Liu Q; Bouyer C; Adriaenssens E; Hilal G; Ségal-Bendirdjian E
    Mol Cancer; 2018 Apr; 17(1):85. PubMed ID: 29703210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
    Liu C; Fang X; Ge Z; Jalink M; Kyo S; Björkholm M; Gruber A; Sjöberg J; Xu D
    Cancer Res; 2007 Mar; 67(6):2626-31. PubMed ID: 17363582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1.
    Günes C; Lichtsteiner S; Vasserot AP; Englert C
    Cancer Res; 2000 Apr; 60(8):2116-21. PubMed ID: 10786671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSA-induced DNMT1 down-regulation represses hTERT expression via recruiting CTCF into demethylated core promoter region of hTERT in HCT116.
    Choi JH; Min NY; Park J; Kim JH; Park SH; Ko YJ; Kang Y; Moon YJ; Rhee S; Ham SW; Park AJ; Lee KH
    Biochem Biophys Res Commun; 2010 Jan; 391(1):449-54. PubMed ID: 19914212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells.
    Chatagnon A; Bougel S; Perriaud L; Lachuer J; Benhattar J; Dante R
    Carcinogenesis; 2009 Jan; 30(1):28-34. PubMed ID: 18952593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Mad as a repressor of the human telomerase (hTERT) gene.
    Oh S; Song YH; Yim J; Kim TK
    Oncogene; 2000 Mar; 19(11):1485-90. PubMed ID: 10723141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of both protein kinase A (PKA) type I and PKA type II isozymes is required for retinoid-induced maturation of acute promyelocytic leukemia cells.
    Nguyen E; Gausdal G; Varennes J; Pendino F; Lanotte M; Døskeland SO; Ségal-Bendirdjian E
    Mol Pharmacol; 2013 May; 83(5):1057-65. PubMed ID: 23455313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
    Hou M; Wang X; Popov N; Zhang A; Zhao X; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu D
    Exp Cell Res; 2002 Mar; 274(1):25-34. PubMed ID: 11855854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.